Israel’s largest healthcare provider has reported a 94pc drop in symptomatic Covid-19 infections among 600,000 people who received two doses of the Pfizer’s vaccine in the country’s biggest study to date.
A study by Israel’s largest healthcare provider on Sunday found that after participants received two doses of Pfizer's coronavirus vaccine, they saw a 94% drop in symptomatic COVID-19 infections, according to a report.
The study, the biggest to date in Israel, compared 600,000 patients given two doses of the vaccine against a same-sized group who had matching medical histories but were not jabbed yet.